| Nanomedicine | |
| Cover: | Nanomedicine_journal_cover.jpg |
| Former Names: | --> |
| Abbreviation: | Nanomedicine (Lond.) |
| Discipline: | Nanomedicine |
| Editor: | Kostas Kostarelos, Charles R. Martin |
| Publisher: | Future Medicine Ltd |
| History: | 2006–present |
| Frequency: | Biweekly |
| Impact: | 4.727 |
| Impact-Year: | 2016 |
| Issn: | 1743-5889 |
| Eissn: | 1748-6963 |
| Coden: | NLUKAC |
| Oclc: | 503720580 |
| Website: | http://www.futuremedicine.com/loi/nnm |
| Link5: | --> |
| Link5-Name: | --> |
Nanomedicine is a biweekly peer-reviewed medical journal covering research on medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems, and nanorobotics applications in medicine. It was established in 2006 and is published by Future Medicine. The editors-in-chief are Kostas Kostarelos (University of Manchester) and Charles R. Martin (University of Florida).
The journal is abstracted and indexed in the Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences,[1] Embase/Excerpta Medica,[2] Inspec,[3] Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded,[1] and Scopus.[4] According to the Journal Citation Reports, the journal has a 2016 impact factor of 4.727, ranking it 20th out of 158 journals in the category "Biotechnology & Applied Microbiology"[5] and 24th out of 86 journals in the category "Nanoscience & Nanotechnology".[6]